Omics Landscape in Disease Biomarkers Discovery
Author(s) -
Monica Neagu,
Caterina Longo,
Simone Ribero
Publication year - 2016
Publication title -
disease markers
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 66
eISSN - 1875-8630
pISSN - 0278-0240
DOI - 10.1155/2016/4068252
Subject(s) - biomarker discovery , biomarker , proteomics , omics , computational biology , metabolomics , epigenomics , genomics , cancer biomarkers , biology , bioinformatics , dna microarray , cancer , genome , dna methylation , genetics , gene , gene expression
Biomarker discovery has an accelerated pace is taking advantage of ever growing omics technologies. In the last years we are facing the development of a myriad of technologies searching for the “golden biomarker.” The omics family is constantly adding a new member, such as genomics, proteomics, peptidomics, newer ones, epigenomics, transcriptomics, metabolomics, lipidomics, pharmacogenomics, interactomics, and chronemics, just mentioning a few [1].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom